Home › NDC Lookup › RxCUI directory › RxCUI 1739749

5 ML brivaracetam 10 MG/ML Injection — RxCUI 1739749

RxNorm drug concept · Semantic clinical drug
RxCUI 1739749 Semantic clinical drug · SCD ● Current RxNorm concept 11 FDA products 17 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1739749
Official name5 ML brivaracetam 10 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbrivaracetam 50 MG per 5 ML Injection; brivaracetam 50 MG in 5 ML Injection
FDA products mapped11
Package NDCs mapped17
Reported Medicaid activity (SDUD)174,041 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Brivaracetam Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Briviact injection is used when you temporarily can't swallow tablets or liquid — for example, if you're in the hospital, recovering from a procedure, or having trouble swallowing....
  • Why am I getting brivaracetam as an injection instead of a pill?
  • The most common ones are drowsiness, dizziness, fatigue, and nausea. These tend to be most noticeable early in treatment. Most people manage them fine, but you should avoid driving...
  • What side effects are most common and should I be worried about them?
📖 Read our full Brivaracetam Injection guide →

🕸️ Concept Web — How 5 ML brivaracetam 10 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 5 ML brivaracetam 10 MG/ML Injection RxCUI 1739749

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Brivaracetam 1739745
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Briviact 1739750
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Brivaracetam Injection 1739748
    • Brivaracetam Injectable Product 1739747
    • Brivaracetam Injection [Briviact] 1739752
    • Briviact Injectable Product 1739753
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Brivaracetam 10 MG/ML SCDC · 1739746
  • Brivaracetam Injection SCDF · 1739748
  • Brivaracetam Injectable Product SCDG · 1739747

Brand-Name Concepts

📦 FDA Products & Package NDCs

11 products · 17 package NDCs
17 package NDCs map to RxCUI 1739749 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00121-1075-02 10 VIAL, GLASS in 1 CARTON (0121-1075-02) / 5 mL in 1 VIAL,... Brivaracetam PAI Holdings, LLC dba PAI Pharma 2026-02-23
14335-0420-10 10 VIAL, GLASS in 1 CARTON (14335-420-10) / 5 mL in 1 VIAL,... Brivaracetam Hainan Poly Pharm. Co., Ltd. 2026-02-21
42571-0370-99 10 VIAL in 1 CARTON (42571-370-99) / 5 mL in 1 VIAL (42571-... BRIVARACETAM Micro Labs Limited 2026-03-01
50474-0370-66 1 BOTTLE in 1 CARTON (50474-370-66) / 60 TABLET, FILM COATE... Briviact UCB, Inc. 2016-05-12
50474-0470-09 100 BLISTER PACK in 1 CARTON (50474-470-09) / 1 TABLET, FIL... Briviact UCB, Inc. 2016-05-12
50474-0470-14 1 BLISTER PACK in 1 CARTON (50474-470-14) / 14 TABLET, FILM... Briviact UCB, Inc. 2016-05-12
50474-0470-66 1 BOTTLE in 1 CARTON (50474-470-66) / 60 TABLET, FILM COATE... Briviact UCB, Inc. 2016-05-12
50474-0570-09 100 BLISTER PACK in 1 CARTON (50474-570-09) / 1 TABLET, FIL... Briviact UCB, Inc. 2016-05-12
50474-0570-14 1 BLISTER PACK in 1 CARTON (50474-570-14) / 14 TABLET, FILM... Briviact UCB, Inc. 2016-05-12
50474-0570-66 1 BOTTLE in 1 CARTON (50474-570-66) / 60 TABLET, FILM COATE... Briviact UCB, Inc. 2016-05-12
50474-0670-66 1 BOTTLE in 1 CARTON (50474-670-66) / 60 TABLET, FILM COATE... Briviact UCB, Inc. 2016-05-12
50474-0770-09 100 BLISTER PACK in 1 CARTON (50474-770-09) / 1 TABLET, FIL... Briviact UCB, Inc. 2016-05-12
50474-0770-14 1 BLISTER PACK in 1 CARTON (50474-770-14) / 14 TABLET, FILM... Briviact UCB, Inc. 2016-05-12
50474-0770-66 1 BOTTLE in 1 CARTON (50474-770-66) / 60 TABLET, FILM COATE... Briviact UCB, Inc. 2016-05-12
50474-0870-15 1 BOTTLE in 1 CARTON (50474-870-15) / 300 mL in 1 BOTTLE Briviact UCB, Inc. 2016-05-12
50474-0970-75 10 VIAL, GLASS in 1 CARTON (50474-970-75) / 5 mL in 1 VIAL,... Briviact UCB, Inc. 2016-05-12
72205-0272-07 10 VIAL, GLASS in 1 CARTON (72205-272-07) / 5 mL in 1 VIAL,... Brivaracetam Novadoz Pharmaceuticals LLC 2026-02-23
Observed labelers: UCB, Inc. (13) · Hainan Poly Pharm. Co., Ltd. (1) · Micro Labs Limited (1) · Novadoz Pharmaceuticals LLC (1) · PAI Holdings, LLC dba PAI Pharma (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.